Results 161 to 170 of about 1,886,678 (184)

A beacon of inclusion for our whole community: Examining a civic university through the lens of LGBTQ+ inclusion

open access: yesBritish Educational Research Journal, EarlyView.
Abstract This exploratory article explores how one UK university sought to understand and enhance its engagement with the local LGBTQ+ community. Drawing on poststructuralist queer and homonormative theories and civic university frameworks, the study analyses data from a community‐facing Pride survey completed by 53 LGBTQ+ individuals. Through emergent
Catherine Lee, Daniel Burman
wiley   +1 more source

Identification of Putative Cellulose Synthase Gene xcsA2 Required for c‐di‐GMP‐Induced Biofilm Formation and Cell Aggregation in Synechococcus elongatus PCC 7942

open access: yesBiotechnology and Bioengineering, EarlyView.
ABSTRACT Synechococcus elongatus PCC 7942 is a widely used model cyanobacterium for diverse research fields and for bioproduction applications owing to its ease of cultivation, genetic modification, and ability to fix CO2. We found that a laboratory strain of S. elongatus PCC 7942 expressing the ydeH gene from E.
Chihiro C. Yamaguchi   +3 more
wiley   +1 more source

Reper intraocular lens with artificial iris: Presentation and outcomes in patients with significant iris defects and Aphakia. [PDF]

open access: yesIndian J Ophthalmol
Gomel N   +8 more
europepmc   +1 more source

Homologous tumor‐targeting biomimetic nanozyme for synergistic NIR‐II photothermal and chemodynamic therapy

open access: yesBMEMat, EarlyView.
Studies reveal that a biomimetic nanoplatform based on a cancer cell membrane‐camouflaged Au‐MnOx nanozyme (Au‐MnOx@CCM) can achieve synergistic antitumor therapy by combining NIR‐II mediated PTT with enhanced CDT, offering a promising strategy for precise and efficient tumor therapy. Abstract The therapeutic potential of nanozyme‐mediated chemodynamic
Xiaonan Li   +6 more
wiley   +1 more source

Letter contrast sensitivity validation. [PDF]

open access: yesOphthalmic Physiol Opt
Guillon M, Pepe P, Hull J, Suryakumar R.
europepmc   +1 more source

Integrated spherical nucleic acid nanoreactor mobilizes targeted PD‐L1 proteolysis and cuproptosis for robust breast cancer immunotherapy

open access: yesBMEMat, EarlyView.
This study provides an integrated spherical nucleic acid nanoreactor (denoted as AMCuD) for targeted PD‐L1 degradation and chemo‐dynamically enhanced cuproptosis to synergically elicit robust immunotherapy against the triple‐negative breast cancer (TNBC) growth, recurrence and metastasis.
Ningxi Li   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy